Gibson Dunn Reps Accuray In $277M Radiotherapy Deal

By Sherry Mazzocchi · March 7, 2011, 7:25 PM EST

California radiation oncology company Accuray on Monday announced plans to buy TomoTherapy Inc. for $277 million, creating a new global cancer treatment provider expected to pull in annual revenue of more...

To view the full article, register now.